Articles Archives - Page 295 of 715

MondayFeb 14, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Seeks EUA to Test Cannabis Product Against COVID Virus, Building on Early Study Results as it Names New Chief Strategy Officer

Recent research efforts have targeted the potential of cannabis compounds to combat COVID-19 infection as the worldwide pandemic presses forward into its third year Perhaps most notable among the early-stage research efforts is a study by Oregon State University that found high doses of two specific cannabinoids bound to spike proteins such as COVID’S SARS-CoV-2 and inhibited their potential for infection Cannabis cultivator and brand builder Flora Growth Corp. has filed a provisional patent application for a cannabinoid-based formula that it is simultaneously seeking approval from Colombia’s food and drug regulatory authority for a study and potential clinical trial in…

MondayFeb 14, 2022 9:30 am

Nemaura Medical Inc.’s (NASDAQ: NMRD) CEO Dr. Faz Chowdhury Addresses Growing CGM Demand at H.C. Wainwright BioConnect Conference

NMRD CEO Dr. Faz Chowdhury presented at H.C. Wainwright BioConnect Conference held January 10-13, 2022 Presentation revealed growing need for CGM devices, diabetes market estimated at $150 billion NMRD's sugarBEAT(R) devices measure glucose at the skin surface, non-invasive, easy to use NMRD recently commenced product shipments in lieu of an order for 5,000 CGM devices and 200,000 sensors to UK licensing partner MySugarWatch Limited NMRD recently announced launch of Miboko metabolic health program targeted at global employers and insurers Dr. Faz Chowdhury, CEO of Nemaura Medical (NASDAQ: NMRD), recently presented at the H.C. Wainwright BioConnect Conference on January 10-13, 2022,…

MondayFeb 14, 2022 9:15 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives IRB Approval for Kernel Flow Feasibility Study

Institution Review Board gives green light to study designed around Kernel’s quantitative neuroimaging technology Kernel Flow device provides ability to measure longitudinal brain activity before, during and after a psychedelic experience CYBN CEO says results from study will further support company’s mission to develop psychedelics into therapeutics Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received approval to move forward on a key feasibility study designed to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics (https://ibn.fm/f0HXk). The approval, granted by the Institution Review Board (“IRB”), gives a green light to a Cybin-sponsored study…

MondayFeb 14, 2022 9:00 am

Physics, Cost, Favor FuelPositive Corp.’s (TSX.V: NHHH) (OTCQB: NHHHF) Vision of Using Green Ammonia as a Vector for Hydrogen; Company Provides Corporate Update

Ammonia is less expensive to transport long-distance via seaborne vessels than liquid hydrogen Ammonia has a lower boil-off rate and higher volumetric energy density than liquid hydrogen; additionally, an ammonia carrier requires less capital investment than a liquid hydrogen transportation vessel FuelPositive holds that green ammonia is a perfect substitute for transporting and storing hydrogen because of existing infrastructure The company recently provided a corporate update in which it detailed the progress of the building of the first demonstration systems for its green ammonia production technology While the hydrogen economy envisions a decarbonized future where green hydrogen is used to…

FridayFeb 11, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Shows Promise in Improving Performance, Speed of ED Drugs

Health and wellness drug bio-effectiveness innovator Lexaria Bioscience is advancing human testing of its patented DehydraTECH(TM) technology for the potential treatment of high blood pressure and heart disease Lexaria also recently announced that DehydraTECH boosted the speed and effectiveness of sildenafil in laboratory rats for the potential treatment of erectile dysfunction (“ED”) The company’s statement notes that DehydraTECH-processed sildenafil “delivered 74% more sildenafil into the bloodstream on average than the concentration-matched, generic control formulation” ED affects some 30 million men in the United States and is expected to affect about 322 million men worldwide by 2025 Lexaria Bioscience (NASDAQ: LEXX),…

FridayFeb 11, 2022 9:30 am

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Marks Another Key Milestone in its 2022 Accelerated Distribution Plan Following Expansion Into HEB Grocery Stores

Eat Well Group’s majority-owned portfolio company, Amara, will now be available in 200 HEB grocery stores in the United States This move strengthens the company’s retail shelf footprint and adds to the growing number of brick and mortar stores stocking Amara products, including Walmart Canada, Whole Foods, Loblaws, and Sprouts Farmers’ Market Amara’s management is optimistic that this milestone will be integral to the company strengthening its brand and increasing its sales going forward At the beginning of the year, Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) announced its Amara Organic Foods' expanded distribution to Walmart Canada and Walmart’s…

FridayFeb 11, 2022 9:15 am

Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) Delic Labs to Present Latest Results and Insights from Its Extensive Experimental Studies on Cannabis Extraction at the Emerald Conference on February 28

Delic Lab’s President and Chief Science Officer, Dr. Markus Roggen, will present at the upcoming Emerald Conference on February 28 Delic Labs is a federally licensed research laboratory operating as part of the Delic Holdings ecosystem The laboratory focuses on extraction optimization, analytical testing, and chemical product and process development and is likely to continue supporting the cannabis industry with the latest technology and services as the cannabis market and cannabis extraction spaces mature Delic Holdings (CSE: DELC) (OTCQB: DELCF) recently announced that Dr. Markus Roggen – the President and Chief Science Officer of Delic Labs, a federally licensed cannabis…

FridayFeb 11, 2022 9:00 am

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Benefits from Court Decision Permitting Bidi Vapors to Resume Sales

On February 1, 2022, Kaival Brands’ product partner, Bidi Vapors LLC was granted a judicial stay on the marketing denial order issued by the US FDA, enabling the company to resume sale of their products within the US market The legal action comes after the FDA moved to oust over 946,000 vaping products from the market through the issuance of blanket MDO’s whilst approving only 3 over the course of a year-long review Bidi Vapor LLC sought to contest the MDO, arguing that their near-285,000-page PMTA filing contained robust and reliable scientific data touting the benefits of their flavored BIDI(R)…

ThursdayFeb 10, 2022 9:30 am

The Alternative Products Expo To Offer Important Networking Opportunities

The Alternative Products Expo presented by 3Chi arrives in Fort Lauderdale March 11-13 to feature the scope and potential of all innovative products and services of the alternative products ecosystem. Organized by ZJ Events, the event group is committed to bringing the industry’s best alternative products traders, vendors, and enthusiasts under one roof, while offering a fun and exciting experience. Having conducted its CBD shows in the top cities of America, ZJ Events is all set to host an exciting new event in Fort Lauderdale, The Alternative Products Expo. The alternative product category includes herbal products, mood enhancers, cannabis derivatives,…

ThursdayFeb 10, 2022 9:15 am

Friendable Inc. (FDBL) Announces Key Metrics Driving Growth of Fan Pass Live Artist Platform; Details February Contest

The acquisition of Artist Republik, in addition to the flagship offering (Fan Pass Live), has created an all-inclusive opportunity for artists on the platform – creating the optimal “anti-label” solution The company reported 14,000% YOY on revenue and 8,000% YOY on its artist portfolio Social media metrics show increased growth in all three channels – Instagram, Facebook, and Twitter After the recent key acquisition of music distribution company Artist Republik, Friendable (OTC: FDBL) is pleased to announce a significant increase in key metrics, driving the growth of its flagship offering, the Fan Pass Live artist platform. Now positioned as the…

Site Search

Company Search

Category: Articles